199 related articles for article (PubMed ID: 33284799)
1. Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children.
Gwee A; Duffull S; Zhu X; Tong SYC; Cranswick N; McWhinney B; Ungerer J; Francis J; Steer AC
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008886. PubMed ID: 33284799
[TBL] [Abstract][Full Text] [Related]
2. Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community.
Kearns TM; Speare R; Cheng AC; McCarthy J; Carapetis JR; Holt DC; Currie BJ; Page W; Shield J; Gundjirryirr R; Bundhala L; Mulholland E; Chatfield M; Andrews RM
PLoS Negl Trop Dis; 2015 Oct; 9(10):e0004151. PubMed ID: 26516764
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial.
Romani L; Marks M; Sokana O; Nasi T; Kamoriki B; Cordell B; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Kaldor JM; Steer AC
Lancet Infect Dis; 2019 May; 19(5):510-518. PubMed ID: 30956111
[TBL] [Abstract][Full Text] [Related]
4. Ivermectin for Sarcoptes scabiei hyperinfestation.
Huffam SE; Currie BJ
Int J Infect Dis; 1998; 2(3):152-4. PubMed ID: 9531662
[TBL] [Abstract][Full Text] [Related]
5. Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study).
Lake SJ; Phelan SL; Engelman D; Sokana O; Nasi T; Boara D; Gorae C; Schuster T; Grobler AC; Osti MH; Andrews R; Marks M; Whitfeld MJ; Romani L; Kaldor J; Steer A
BMJ Open; 2020 Aug; 10(8):e037305. PubMed ID: 32868360
[TBL] [Abstract][Full Text] [Related]
6. Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin.
del Mar Sáez-De-Ocariz M; McKinster CD; Orozco-Covarrubias L; Tamayo-Sánchez L; Ruiz-Maldonado R
Clin Exp Dermatol; 2002 Jun; 27(4):264-7. PubMed ID: 12139665
[TBL] [Abstract][Full Text] [Related]
7. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study.
Levy M; Martin L; Bursztejn AC; Chiaverini C; Miquel J; Mahé E; Maruani A; Boralevi F;
Br J Dermatol; 2020 Apr; 182(4):1003-1006. PubMed ID: 31344258
[TBL] [Abstract][Full Text] [Related]
8. Community control strategies for scabies: A cluster randomised noninferiority trial.
Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Schuster T; Grobler AC; Engelman D; Robinson LJ; Kaldor JM; Steer AC
PLoS Med; 2021 Nov; 18(11):e1003849. PubMed ID: 34758017
[TBL] [Abstract][Full Text] [Related]
9. National survey in Switzerland calls for improved diagnosis and treatment in children with scabies.
Buettcher M; Stebler AK; Theiler M; Kobylinski K; Pfister M
Swiss Med Wkly; 2023 Nov; 153():40129. PubMed ID: 38579328
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin.
Marks M; Romani L; Sokana O; Neko L; Harrington R; Nasi T; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Kaldor JM; Steer AC
Clin Infect Dis; 2020 Apr; 70(8):1591-1595. PubMed ID: 31131410
[TBL] [Abstract][Full Text] [Related]
11. Ivermectin use in scabies.
Fawcett RS
Am Fam Physician; 2003 Sep; 68(6):1089-92. PubMed ID: 14524395
[TBL] [Abstract][Full Text] [Related]
12. Treatment of scabies: comparison of ivermectin vs. lindane lotion 1%.
Mohebbipour A; Saleh P; Goldust M; Amirnia M; Zadeh YJ; Mohamadi RM; Rezaee E
Acta Dermatovenerol Croat; 2012; 20(4):251-5. PubMed ID: 23317486
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of scabies with oral ivermectin in Nigeria.
Nnoruka EN; Agu CE
Trop Doct; 2001 Jan; 31(1):15-8. PubMed ID: 11205591
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers.
Duthaler U; Suenderhauf C; Karlsson MO; Hussner J; Meyer Zu Schwabedissen H; Krähenbühl S; Hammann F
Br J Clin Pharmacol; 2019 Mar; 85(3):626-633. PubMed ID: 30566757
[TBL] [Abstract][Full Text] [Related]
15. Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and Adults.
Brussee JM; Schulz JD; Coulibaly JT; Keiser J; Pfister M
Clin Pharmacol Ther; 2019 Sep; 106(3):661-667. PubMed ID: 30993667
[TBL] [Abstract][Full Text] [Related]
16. Ivermectin for scabies.
Dugdale A
J Paediatr Child Health; 2003 Jul; 39(5):392-3. PubMed ID: 12887676
[No Abstract] [Full Text] [Related]
17. Successful use of ivermectin in the treatment of endemic scabies in a nursing home.
Sullivan JR; Watt G; Barker B
Australas J Dermatol; 1997 Aug; 38(3):137-40. PubMed ID: 9293660
[TBL] [Abstract][Full Text] [Related]
18. Ivermectin: new indication. Oral treatment of scabies: simple and effective.
Prescrire Int; 2002 Oct; 11(61):137-40. PubMed ID: 12378743
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, Diagnosis, and Treatment of Scabies in a Dermatology Office.
Anderson KL; Strowd LC
J Am Board Fam Med; 2017 Jan; 30(1):78-84. PubMed ID: 28062820
[TBL] [Abstract][Full Text] [Related]
20. The use of ivermectin in controlling an outbreak of scabies in a prison.
Leppard B; Naburi AE
Br J Dermatol; 2000 Sep; 143(3):520-3. PubMed ID: 10971323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
